TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)

BACKGROUND: The optimal management of patients with resectable gastric cancer continues to evolve in Western countries. Following publication of the US Intergroup 0116 and UK Medical Research Council MAGIC trials, there are now two standards of care for adjuvant therapy in resectable gastric cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Leong, Trevor, Smithers, B Mark, Michael, Michael, Gebski, Val, Boussioutas, Alex, Miller, Danielle, Simes, John, Zalcberg, John, Haustermans, Karin, Lordick, Florian, Schuhmacher, Christoph, Swallow, Carol, Darling, Gail, Wong, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507314/
https://www.ncbi.nlm.nih.gov/pubmed/26194186
http://dx.doi.org/10.1186/s12885-015-1529-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507314/
https://www.ncbi.nlm.nih.gov/pubmed/26194186
http://dx.doi.org/10.1186/s12885-015-1529-x

Ejemplares similares